ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Agriculture

UK’s Genus, Beijing Capital to gene edit a pig

by Melody M. Bomgardner
May 25, 2019 | APPEARED IN VOLUME 97, ISSUE 21

 

09721-buscon10-pig.jpg
Credit: Shutterstock
Gene editing could create pigs resistant to deadly viruses.

The British livestock breeding firm Genus has inked a deal with Beijing Capital Agribusiness (BCA) to develop pigs gene-edited to resist the porcine reproductive and respiratory syndrome virus. BCA is part of a Chinese state-owned conglomerate. The firm will provide Genus with up-front and milestone payments of $20 million. Once China approves the gene-edited pig, the two firms plan to launch a joint venture. China, the world’s largest pork market, is working to modernize pork production but has been hindered by disease outbreaks.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment